Through the partnership, UMC Utrecht will use Paige’s suite of AI prostate health tools, and clinicians will report on the efficiency of diagnoses provided by these AI tools, according to a Nov. 16 Paige news release.
In addition to prostate cancer detection, UMC Utrecht will evaluate Paige’s AI tool that aims to detect if breast cancer has metastasized to lymph nodes.
“UMC Utrecht and Paige share a vision to improve outcomes for patients with cancer and health systems by leveraging quality AI solutions that help standardize the cancer diagnosis process,” Paige CEO Andy Moye, PhD, said. “Specifically, this collaboration builds on pioneering work from Utrecht which demonstrated large systemic variability in Gleason scoring of prostate biopsies nationwide in the Netherlands. Paige’s AI software can help overcome these diagnostic challenges. This partnership marks another significant milestone in our efforts to modernize and improve the process of cancer diagnosis globally.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
